A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL

Experts address audience questions from a live symposium on AML treatment strategies and future therapy directions, from Clinical Care Options (CCO)

Daniel Pollyea, MD, MS
Program Director Courtney DiNardo, MD, MSCE Eytan M. Stein, MD Released: January 24, 2023

Clinical Care Options (CCO): Expertos repasan los principales datos sobre LLC y LCM de las juntas de ASCO, EHA, la Conferencia Pan-Pacífico sobre Linfomas, ESMO y SOHO de 2022

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 23, 2023

Downloadable resource designed to serve as a helpful guide for healthcare professionals on newer therapies for patients with follicular lymphoma, from Clinical Care Options (CCO)

Downloadable slideset on recent advances in the clinical management of patients with CLL, from Clinical Care Options (CCO)

Jennifer R. Brown, MD, PhD Jeff Sharman, MD Released: January 19, 2023